FDA Grants Fast Track Status to Intranasal Pertussis Vaccine
The designation is supported by data from 4 clinical trials evaluating BPZE1 in healthy adults.
Immunization
Supplemental BLA Submitted for Pfizer-BioNTech COVID-19 Vaccine for 12- to 15-Year-Olds
The application is supported by data from a randomized, placebo-controlled phase 3 trial which included 2228 participants 12 to 15 years of age enrolled in the United States.
Update on the Safety and Efficacy of MMR/MMRV Vaccines in Pediatric Patients
Researchers conducted a study to assess the effectiveness, safety, and adverse effects associated with the measles-mumps-rubella and varicella vaccines in children aged 15 years and younger.
Efficacy of the NVX-CoV2373 COVID-19 Vaccine Co-Administered With Seasonal Influenza Vaccines
Researchers conducted a study to assess the efficacy of the NVX-CoV2373 COVID-19 vaccine when co-administered with a seasonal influenza vaccine.
Anti-Idiotype Immune Responses in SARS-CoV-2 Infection and Vaccination
Researchers sought to investigate the potential role of anti-idiotype antibodies in SARS-CoV-2 infection and vaccination.
Guidelines for Vaccinating Pregnant Women
Special recommendations and contraindications for vaccinating pregnant woman.
Risk for Atopic Disease in Children who Receive the Whole-Cell Pertussis Vaccine in Early Infancy
Researchers conducted a study that compared the safety and efficacy of whole-cell vs acellular pertussis vaccines for the prevention of atopic diseases in children.
Risk for Adverse COVID-19 Outcomes in Patients With Immune-Mediated Inflammatory Diseases Treated With TNF Inhibitors
Researchers sought to assess the risk for COVID-19-related hospitalization or death among patients with immune-mediated inflammatory diseases receiving treatment with tumor necrosis factor inhibitors.
Anti-CD20 Therapy for Immune-Mediated Diseases Linked to Increased Mortality Risk in COVID-19
Researchers examined whether treatment with CD20 inhibitors resulted in worse COVID-19 outcomes among patients with immune-mediated diseases.
Effect of a National Human Papillomavirus Immunization Program on Cervical Cancer Incidence
Researchers conducted a study to determine the effect of a national human papillomavirus (HPV) immunization program on the incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia among young women in England.
- Loading...
Loading...
Next post in Prevention
Loading... 
Loading...